Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Life In The Donut Hole: OIG Offers Glimpse Into Part D Prescription Habits

This article was originally published in The Pink Sheet Daily

Executive Summary

In a study of Medicare Part D beneficiaries who entered the coverage gap and had no financial assistance, the HHS Office of Inspector General finds 69 percent decreased the number of drugs purchased.

You may also be interested in...



Changing Part D Donut Hole “A Very Expensive Fix,” Daschle Notes

Changing the "donut hole" in Medicare Part D drug reimbursement and allowing the government to negotiate prices for seniors' medicines will be on the table as the Obama Administration develops its health care proposals

Nearly A Quarter Of Diabetes Patients Altered Therapy In Part D Gap – Study

Twenty-three percent of a large sample of Medicare Part D enrollees taking oral drugs for diabetes changed their medication use when they reached the gap in coverage, according to a study released by the Kaiser Family Foundation Aug. 21

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel